Panobinostat
Showing 126 - 149 of 149
Leukemia Trial in Duarte, South Pasadena, Seattle (drug, genetic, other)
Completed
- Leukemia
- imatinib mesylate
- +7 more
-
Duarte, California
- +2 more
Aug 14, 2014
Peripheral T-cell Lymphoma (Not Otherwise Specified), Angioimmunoblastic T-cell Lymphoma, Extranodal NK/T-cell Lymphoma Nasal
Completed
- Peripheral T-cell Lymphoma (Not Otherwise Specified)
- +6 more
- panobinostat and bortezomib
-
Seoul, Korea, Republic of
- +4 more
Jun 26, 2014
Multiple Myeloma Trial in United States (Melphalan, Panobinostat)
NSCLC Trial in Pittsburgh (LBH 589, Pemetrexed)
Terminated
- Non-Small Cell Lung Cancer
- LBH 589
- Pemetrexed
-
Pittsburgh, PennsylvaniaHillman Cancer Center
Jul 20, 2015
HIV Infection Trial in Aarhus (Panobinostat)
Completed
- HIV Infection
- Panobinostat
-
Aarhus, DenmarkDepartment of Infectious Diseases, Aarhus University Hospital
Feb 24, 2014
Hodgkin's Lymphoma Trial in Rozzano (panobinostat, Ifosfamide, Gemcitabine)
Unknown status
- Hodgkin's Lymphoma
- panobinostat
- +4 more
-
Rozzano, MI, ItalyIstituto Clinico Humanitas
Jan 28, 2014
Breast Cancer, Breast Tumors, Breast Tumors Trial in Atlanta (Decitabine, LBH589, Tamoxifen)
Terminated
- Breast Cancer
- +2 more
- Decitabine, LBH589, Tamoxifen
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Jan 18, 2015
Non-Hodgkin's Lymphoma Trial in Tampa (LBH589)
Terminated
- Non-Hodgkin's Lymphoma
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 21, 2013
Recurrent Glioblastoma Trial in Durham (panobinostat)
Withdrawn
- Recurrent Glioblastoma
- panobinostat
-
Durham, North CarolinaDuke University Medical Center
Jun 17, 2013
Chronic GVHD Trial in Nashville (LBH589, Methylprednisolone)
Withdrawn
- Chronic Graft-Versus-Host Disease
-
Nashville, TennesseeTennessee Oncology, PLLC
Feb 11, 2013
Metastatic Gastric Cancer Trial in Munic, Mannheim (Panobinostat (LBH589))
Terminated
- Metastatic Gastric Cancer
- Panobinostat (LBH589)
-
Munic, Bavaria, Germany
- +1 more
Apr 30, 2013
Soft Tissue Sarcoma Trial in Lyon (LBH589 (Panobinostat®))
Completed
- Soft Tissue Sarcoma
- LBH589 (Panobinostat®)
-
Lyon, FranceCentre Léon Berard
Mar 5, 2013
Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Duarte, Pasadena (everolimus, panobinostat, laboratory biomarker
Completed
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- everolimus
- +3 more
-
Duarte, California
- +1 more
Feb 13, 2013
Solid Tumors Trial in Nashville (LBH589, Gemcitabine)
Terminated
- Solid Tumors
- LBH589, Gemcitabine
-
Nashville, TennesseeTennessee Oncology, PLLC
Aug 15, 2013
Advanced Solid Tumors Trial in Durham (Bevacizumab, Everolimus and LBH589)
Completed
- Advanced Solid Tumors
- Bevacizumab, Everolimus and LBH589
-
Durham, North CarolinaDuke University Medical Center
Dec 21, 2012
Liver Cancer Trial in Cleveland (panobinostat, sorafenib tosylate)
Terminated
- Liver Cancer
- panobinostat
- sorafenib tosylate
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Mar 16, 2012
Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies Trial in Buffalo (LBH589)
Completed
- Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies
-
Buffalo, New YorkNovartis Investigative Site
Apr 27, 2012
Chordoma Trial in Boston, Ann Arbor, Charlottesville (Imatinib + LBH589)
Unknown status
- Chordoma
- Imatinib + LBH589
-
Boston, Massachusetts
- +2 more
Dec 26, 2012
Advanced Solid Tumors Trial in Basel, Bellinzona, Lausanne (Panobinostat (LBH589), Carboplatin and Paclitaxel)
Unknown status
- Advanced Solid Tumors
- Panobinostat (LBH589), Carboplatin and Paclitaxel
-
Basel, Switzerland
- +2 more
Sep 12, 2011
Recurrent Malignant Gliomas Trial in Commack, Great Neck (Panobinostat)
Terminated
- Recurrent Malignant Gliomas
- Panobinostat
-
Commack, New York
- +1 more
Jul 15, 2010
Solid Tumors Trial in Nashville (LBH589, Paclitaxel, Carboplatin, Bevacizumab)
Completed
- Solid Tumors
- LBH589, Paclitaxel, Carboplatin, Bevacizumab
-
Nashville, TennesseeTennessee Oncology, PLLC
Dec 29, 2010
Hormone Refractory Prostate Cancer Disease Trial in Boston, St. Louis, New York (LBH589)
Terminated
- Hormone Refractory Prostate Cancer Disease
-
Boston, Massachusetts
- +2 more
Apr 7, 2010